» Articles » PMID: 17826802

Effects of Honokiol and Magnolol on Acute and Inflammatory Pain Models in Mice

Overview
Journal Life Sci
Publisher Elsevier
Date 2007 Sep 11
PMID 17826802
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

The antinociceptive actions of honokiol and magnolol, two major bioactive constituents of the bark of Magnolia officinalis, were evaluated using tail-flick, hot-plate and formalin tests in mice. The effects of honokiol and magnolol on the formalin-induced c-Fos expression in the spinal cord dorsal horn as well as motor coordination and cognitive function were examined. Data showed that honokiol and magnolol did not produce analgesia in tail-flick, hot-plate paw-shaking and neurogenic phase of the overt nociception induced by intraplantar injection of formalin. However, honokiol and magnolol reduced the inflammatory phase of formalin-induced licking response. Consistently, honokiol and magnolol significantly decreased formalin-induced c-Fos protein expression in superficial (I-II) laminae of the L4-L5 lumbar dorsal horn. However, honokiol and magnolol did not elicit motor incoordination and memory dysfunction at doses higher than the analgesic dose. These results demonstrate that honokiol and magnolol effectively alleviate the formalin-induced inflammatory pain without motor and cognitive side effects, suggesting their therapeutic potential in the treatment of inflammatory pain.

Citing Articles

Phytochemical-based therapeutics from traditional eastern medicine: analgesic effects and ion channel modulation.

Kim S, Chung G, Kim S Front Pain Res (Lausanne). 2025; 6:1537154.

PMID: 39958366 PMC: 11825757. DOI: 10.3389/fpain.2025.1537154.


Sirtuins in intervertebral disc degeneration: current understanding.

Shen J, Lan Y, Ji Z, Liu H Mol Med. 2024; 30(1):44.

PMID: 38553713 PMC: 10981339. DOI: 10.1186/s10020-024-00811-0.


Rab11a in the spinal cord: an essential contributor to complete Freund's adjuvant-induced inflammatory pain in mice.

Gu J, Wang J, Ma F, Liu M, Chen S, Wei Y Mol Brain. 2023; 16(1):70.

PMID: 37770900 PMC: 10537208. DOI: 10.1186/s13041-023-01057-3.


Efficacy analysis and research progress of complementary and alternative medicines in the adjuvant treatment of COVID-19.

Lin J, Huang G, Su Y J Biomed Sci. 2023; 30(1):30.

PMID: 37138292 PMC: 10155165. DOI: 10.1186/s12929-023-00923-5.


Chinese herbal prescriptions for COVID-19 management: Special reference to Taiwan Chingguan Yihau (NRICM101).

Su Y, Huang G, Lin J Front Pharmacol. 2022; 13:928106.

PMID: 36278162 PMC: 9581083. DOI: 10.3389/fphar.2022.928106.